These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6367796)

  • 21. Labetalol in mild and moderate hypertension. A report from the General Practitioner Research Group.
    Practitioner; 1980 Sep; 224(1347):945-9. PubMed ID: 7003576
    [No Abstract]   [Full Text] [Related]  

  • 22. Timolol maleate and hydrochlorothiazide in control of essential hypertension: use of a fixed combination for once-a-day administration.
    Schwartz FN; Tiffany J
    J Am Osteopath Assoc; 1981 May; 80(9):590-4. PubMed ID: 7019167
    [No Abstract]   [Full Text] [Related]  

  • 23. Controlled evaluation of bendroflumethiazide in the treatment of essential hypertension.
    Spitzer TQ; Harris BA
    Curr Ther Res Clin Exp; 1975 Jan; 17(1):75-9. PubMed ID: 806431
    [No Abstract]   [Full Text] [Related]  

  • 24. A general practice study of timolol/hydrochlorothiazide/amiloride ('Moducren'), a new therapy for hypertension, and the doctor's influence on management.
    Parry EE; Arr S; Tait D
    Pharmatherapeutica; 1983; 3(5):294-9. PubMed ID: 6844366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Do elderly patients respond differently to treatment with Moducren?
    Currie WJ; Vandenburg MJ; Cooper WD
    Br J Clin Pract; 1984 Mar; 38(3):102-6, 119. PubMed ID: 6712874
    [No Abstract]   [Full Text] [Related]  

  • 26. [Docidrazin. Long-term observation with a 3-component antihypertensive agent].
    Degenring FH
    ZFA (Stuttgart); 1983 Mar; 59(8):476-8. PubMed ID: 6407227
    [No Abstract]   [Full Text] [Related]  

  • 27. Practolol and bendrofluazide in treatment of hypertension.
    Galloway DB; Beattie AG; Petrie JC
    Br Heart J; 1974 Sep; 36(9):867-71. PubMed ID: 4609447
    [No Abstract]   [Full Text] [Related]  

  • 28. [Beta-blockers or thiazides for middle-aged and elderly patients with hypertension? A multicenter study in general practice].
    Andersen GS
    Ugeskr Laeger; 1986 Aug; 148(35):2212-3. PubMed ID: 3535193
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical trials with hypertensive patients in general practice].
    Hagelund CH; Tretli S
    Tidsskr Nor Laegeforen; 1980 Jan; 100(3):159-65. PubMed ID: 6992340
    [No Abstract]   [Full Text] [Related]  

  • 30. [A 10-year follow-up of men with mild hypertension. Bendroflumethiazide and propranolol give equal effect in treatment of high blood pressure].
    Andersson OK; Widgren B; Berglund G
    Lakartidningen; 1985 Mar; 82(13):1159-62. PubMed ID: 3887074
    [No Abstract]   [Full Text] [Related]  

  • 31. A placebo controlled trial of Tenavoid in the management of the premenstrual syndrome.
    Carstairs MW; Talbot DJ
    Br J Clin Pract; 1981; 35(11-12):403-9. PubMed ID: 7030376
    [No Abstract]   [Full Text] [Related]  

  • 32. Mild hypertension: a clinical trial conducted in hospital general practice.
    Joesbury HE; Phillips CA; Garrett RT; Wilkes E; Smith AJ
    Br Med J; 1976 Dec; 2(6050):1476-9. PubMed ID: 793680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term treatment of hypertension with a preparation combining rauwolfia and bendroflumethiazide.
    Hutchison JC
    Med Times; 1967 Aug; 95(8):860-8. PubMed ID: 6046238
    [No Abstract]   [Full Text] [Related]  

  • 34. [Timolol (Betim) in the treatment of essential hypertension in general practice. Single-dose and two-doses compared].
    Frimodt-Møller F; Arnold-Larsen AE
    Ugeskr Laeger; 1981 Feb; 143(9):544-5. PubMed ID: 7025413
    [No Abstract]   [Full Text] [Related]  

  • 35. Adjuvant effect of bendrofluazide on propranolol in hypertension.
    Mitchell I; Lodge R; Lawson AA
    Scott Med J; 1972 Oct; 17(10):326-9. PubMed ID: 4562883
    [No Abstract]   [Full Text] [Related]  

  • 36. Timolol and a hydrochlorothiazide-amiloride combination in the treatment of essential hypertension in young and middle-aged patients: a comparative study with once-daily administration.
    Lindroos M; Lehtonen A
    Int J Clin Pharmacol Ther Toxicol; 1984 Dec; 22(12):643-5. PubMed ID: 6396239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relative potency of amiloride and spironolactone in bendrofluazide-treated hypertensive patients [proceedings].
    Fraser R; Hettiarachchi J; Morton JJ; Ramsay LE; Shelton J
    Br J Clin Pharmacol; 1978 Nov; 6(5):444P. PubMed ID: 365206
    [No Abstract]   [Full Text] [Related]  

  • 38. The influence of physicians' instructions on the outcome of antihypertensive therapy.
    Cooper WD; Currie WJ; Vandenburg MJ
    Br J Clin Pract; 1983 Mar; 37(3):99-103. PubMed ID: 6882631
    [No Abstract]   [Full Text] [Related]  

  • 39. Amelioration of bendrofluazide-induced hypokalemia by timolol.
    Hettiarachchi J; Ramsay LE; Davies DL; Fraser R; Watson WS
    Clin Pharmacol Ther; 1977 Jul; 22(1):58-62. PubMed ID: 326460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A low dose atenolol/bendrofluazide combination in patients with mild to moderate hypertension.
    Johnston GD; Wilson R; McDermott BJ; Conroy C
    J Hum Hypertens; 1997 Nov; 11(11):759-60. PubMed ID: 9416987
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.